2026. Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia. Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Sep. 2026), e2026069. DOI:https://doi.org/10.4084/MJHID.2026.069.